As the global economy recovers in 2021 and the supply of the industrial chain improves, the Targeted-protein Degradation Therapeutics market will undergo major changes. According to the latest research, the market size of the Targeted-protein Degradation Therapeutics industry in 2022 will increase by USD million compared to 2021, with a growth rate of %.
The global Targeted-protein Degradation Therapeutics industry report provides top-notch qualitative and quantitative information including: Market size (2018-2022 value and 2023 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Targeted-protein Degradation Therapeutics market during the next few years. Market research reports are an essential resource for businesses seeking to maximize the market potential. The report provides extensive data, insights, and analysis to enable businesses to make informed decisions, drive growth, and achieve success.
Highlights-Regions
The Targeted-protein Degradation Therapeutics market can be split based on product types, major applications, and important regions as follows:
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics
Types list
ARV-110
ARV-471
Other
Application list
Cancer
Neuroscience
Other
Table of Content
1 Targeted-protein Degradation Therapeutics Market Introduction and Overview
1.1 Targeted-protein Degradation Therapeutics Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Targeted-protein Degradation Therapeutics Sales and Market Share by Manufacturer
2.2 Global Targeted-protein Degradation Therapeutics Revenue and Market Share by Manufacturer
2.3 Global Targeted-protein Degradation Therapeutics Average Price by Manufacturers
2.4 Manufacturers Targeted-protein Degradation Therapeutics Production Sites, Area Served, Product Types
2.5 Targeted-protein Degradation Therapeutics Market Competitive Situation and Trends
2.5.1 Targeted-protein Degradation Therapeutics Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.5.3 Mergers & Acquisitions, Expansion
3 Global Targeted-protein Degradation Therapeutics Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Targeted-protein Degradation Therapeutics Market Share by Type 2018 VS 2022
3.2 Global Targeted-protein Degradation Therapeutics Revenue and Market Share by Type
3.3 Global Targeted-protein Degradation Therapeutics Sales and Market Share by Type
4 Global Targeted-protein Degradation Therapeutics Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Targeted-protein Degradation Therapeutics Market Share by Application 2018 VS 2022
4.2 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Application (2018-2023)
4.3 Global Targeted-protein Degradation Therapeutics Sales Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Targeted-protein Degradation Therapeutics Market Size (2018-2023)
5.2 Targeted-protein Degradation Therapeutics Growth Trends Analysis by Regions
5.2.1 Targeted-protein Degradation Therapeutics Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Targeted-protein Degradation Therapeutics Historic Revenue Market Size by Regions (2018-2023)
5.2.3 Targeted-protein Degradation Therapeutics Historic Sales Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Targeted-protein Degradation Therapeutics Revenue by Countries (2018-2023)
5.3.2 North America Targeted-protein Degradation Therapeutics Sales by Countries (2018-2023)
5.3.3 North America SWOT Analysis
5.3.4 United States
5.3.5 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Targeted-protein Degradation Therapeutics Revenue by Countries (2018-2023)
5.5.2 Asia Pacific Targeted-protein Degradation Therapeutics Sales by Countries (2018-2023)
5.5.3 Asia Pacific SWOT Analysis
5.5.4 Japan
5.5.5 Korea
5.5.6 Southeast Asia
5.5.7 India
5.5.8 Australia
5.6 EMEA
5.6.1 EMEA Targeted-protein Degradation Therapeutics Revenue by Countries (2018-2023)
5.6.2 EMEA Targeted-protein Degradation Therapeutics Sales by Countries (2018-2023)
5.6.3 EMEA SWOT Analysis
5.6.4 Europe
5.6.5 Middle East
5.6.6 Africa
5.7 Latin America
5.7.1 Latin America Targeted-protein Degradation Therapeutics Revenue by Countries (2018-2023)
5.7.2 Latin America Targeted-protein Degradation Therapeutics Sales by Countries (2018-2023)
5.7.3 Latin America SWOT Analysis
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Mexico
6 Players Profiles
6.1 Arvinas
6.1.1 Arvinas Company Profile
6.1.2 Targeted-protein Degradation Therapeutics Product Overview
6.1.3 Arvinas Targeted-protein Degradation Therapeutics Market Performance (2018-2023)
6.1.4 Arvinas Business Overview
6.1.5 SWOT Analysis
6.2 Nurix Therapeutics
6.2.1 Nurix Therapeutics Company Profile
6.2.2 Targeted-protein Degradation Therapeutics Product Overview
6.2.3 Nurix Therapeutics Targeted-protein Degradation Therapeutics Market Performance (2018-2023)
6.2.4 Nurix Therapeutics Business Overview
6.2.5 SWOT Analysis
6.3 Kymera Therapeutics
6.3.1 Kymera Therapeutics Company Profile
6.3.2 Targeted-protein Degradation Therapeutics Product Overview
6.3.3 Kymera Therapeutics Targeted-protein Degradation Therapeutics Market Performance (2018-2023)
6.3.4 Kymera Therapeutics Business Overview
6.3.5 SWOT Analysis
6.4 C4 Therapeutics
6.4.1 C4 Therapeutics Company Profile
6.4.2 Targeted-protein Degradation Therapeutics Product Overview
6.4.3 C4 Therapeutics Targeted-protein Degradation Therapeutics Market Performance (2018-2023)
6.4.4 C4 Therapeutics Business Overview
6.4.5 SWOT Analysis
7 Targeted-protein Degradation Therapeutics Manufacturing Cost Analysis
7.1 Targeted-protein Degradation Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Targeted-protein Degradation Therapeutics
7.4 Targeted-protein Degradation Therapeutics Industrial Chain Analysis
8 Market Channel, Distributors, Traders and Dealers
8.1 Market Channel Status
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.2 Targeted-protein Degradation Therapeutics Typical Distributors
8.3 Targeted-protein Degradation Therapeutics Typical Customers
9 Targeted-protein Degradation Therapeutics Industry Dynamic Analysis
9.1 Targeted-protein Degradation Therapeutics Market Trends Analysis
9.2 Targeted-protein Degradation Therapeutics Market Drivers Analysis
9.3 Targeted-protein Degradation Therapeutics Market Challenges Analysis
9.4 Targeted-protein Degradation Therapeutics Market Restraints Analysis
10 Global Targeted-protein Degradation Therapeutics Forecast Market Analysis by Type & Application
10.1 Global Targeted-protein Degradation Therapeutics Revenue Market Forecast by Type (2023-2029)
10.2 Global Targeted-protein Degradation Therapeutics Sales Market Forecast by Type (2023-2029)
10.3 Targeted-protein Degradation Therapeutics Revenue Market Forecast by Application (2023-2029)
10.4 Targeted-protein Degradation Therapeutics Sales Market Forecast by Application (2023-2029)
11 Global Targeted-protein Degradation Therapeutics Forecast Market Analysis by Region
11.1 Targeted-protein Degradation Therapeutics Revenue Market Forecast by Region (2023-2029)
11.2 Targeted-protein Degradation Therapeutics Sales Market Forecast by Region (2023-2029)
11.3 North America Targeted-protein Degradation Therapeutics Forecast Market Analysis
11.4 EMEA Targeted-protein Degradation Therapeutics Forecast Market Analysis
11.5 China Targeted-protein Degradation Therapeutics Forecast Market Analysis
11.6 Asia-Pacific Targeted-protein Degradation Therapeutics Forecast Market Analysis
11.7 Latin America Targeted-protein Degradation Therapeutics Forecast Market Analysis
12 Research Findings and Conclusion
Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/north-america[2] https://www.marketresearchreports.com/countries/europe[3] https://www.marketresearchreports.com/countries/china[4] https://www.marketresearchreports.com/countries/japan[5] https://www.marketresearchreports.com/countries/global[6] https://www.marketresearchreports.com/pharmaceutical-manufacturing[7] https://www.marketresearchreports.com/healthcare[8] https://www.marketresearchreports.com/pharma-healthcare